F(ab′)2 segment is the active component of immunoglobulin G autoantibody generation in patients with endometriosis

R A Wild, Robert A. Wild, Diane Medders, D Medders, Renjie Zhang, R J Zhang
Fertility and Sterility · 1991 · vol. 56(5) , pp. 900–903 · doi:10.1016/s0015-0282(16)54662-7 · PMID:1718784 · W2417001378
article OA: closed CC0 ⤵ 7 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-06 ⓘ

This study investigated the F(ab′)2 segment of immunoglobulin G autoantibodies and determined it is the active component responsible for their generation in patients diagnosed with endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Autoantibodies Endometriosis Immunoglobulin Fab Fragments Immunoglobulin G Antibody Formation Autoantibodies Endometriosis Endometriosis Fluorescent Antibody Technique Humans Immunoglobulin Fab Fragments Immunoglobulin Fab Fragments Immunoglobulin G Neoplasm Staging Staining and Labeling Tumor Cells, Cultured

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (14)

Cited by (7)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:11:54.876058+00:00
License: CC0 · commercial use OK